Identify new markers for cancer with qPCR

Identify new markers for cancer with qPCR

Anatomy - Pathology / Cytogenetics / Molecular Diagnostics

December 20, 2016

One of the most exciting potential applications of circulating non-coding RNAs like microRNA (miRNA) and long non-coding RNA (lncRNA) is as biomarkers for early detection of cancer. Easily accessible markers like RNAs in the blood are an attractive possibility for finding cancers as soon as possible. Our scientists have compiled an application note showing how to use qPCR in translational research to identify potential lncRNA biomarkers in lung cancer. Check it out here!

NEW QIAstat-Dx Respiratory 2019-nCoV Panel

NEW QIAstat-Dx Respiratory 2019-nCoV Panel

Anatomy - Pathology / Cytogenetics / Molecular Dia...

To support the research efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN® developed the QIAstat-Dx® Respiratory 2019-nCoV Panel.

December 18, 2020 More +
Blood-based biomarkers for COVID-19

Blood-based biomarkers for COVID-19

Anatomy - Pathology / Cytogenetics / Molecular Dia...

Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.

June 23, 2020 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us